tradmap

USPH Financials U S Physical Therapy Inc /Nv

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 13.0% per year over the past 5 years.
  • Net income has grown slower than revenue (2.4% vs 13.0% per year).
  • Operating margin has contracted, at 11.1% in the latest year.
  • Free cash flow has declined 8.0% per year over the past 5 years.

Financial health

  • Total debt ($162M) exceeds cash ($36M); net debt is $127M.
  • Total debt has grown faster than revenue (49.9% vs 13.0% per year).
  • Total debt is 1.5× EBITDA.

Shareholder returns

  • Dividends have been paid for 15 consecutive years, consuming 69.1% of earnings and 44.9% of free cash flow.
  • The dividend has grown 46.1% per year over the past 5 years.
Revenue & net income
$0 $390M $781M 2011 2013 2015 2017 2019 2021 2023 2025
RevenueNet income
Margins (gross / operating / net)
0% 12% 24% 2011 2013 2015 2017 2019 2021 2023 2025
GrossOperatingNet
Free cash flow (CFO − capex)
$0 $46M $92M 2011 2013 2015 2017 2019 2021 2023 2025
Free cash flow
Cash vs total debt
$0 $92M $184M 2011 2013 2015 2017 2019 2021 2023 2025
CashTotal debt
Cash flow: operating / investing / financing
-$149M -$25M $100M $0 2011 2013 2015 2017 2019 2021 2023 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MFCFTotal debtCash
2025 $781M $40M 19.2% 11.1% $61M $162M $36M
2024 $671M $31M 18.5% 9.4% $66M $154M $41M
2023 $605M $28M 20.1% 8.4% $73M $147M $153M
2022 $553M $32M 20.3% 10.3% $50M $184M $32M
2021 $495M $41M 23.7% 14.3% $68M $118M $29M
2020 $423M $35M 22.3% 12.4% $92M $21M $33M
2019 $482M $40M 23.3% 14.0% $52M $51M $24M
2018 $454M $35M 22.4% 13.3% $66M $40M $23M
2017 $414M $22M 21.9% 13.2% $49M $61M $22M
2016 $357M $21M 23.0% 13.9% $43M $52M $20M
2015 — $21M — — $31M $49M $16M
2014 — $19M — — $40M $36M $14M
2013 — $13M — — $40M $41M $13M
2012 — $18M — — $35M $18M $12M
2011 — $21M — — $29M $24M $10M

Valuation over time

How the market has priced USPH against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 30.3 60.7 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/E
Price / sales (P/S)
0.0 1.7 3.3 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/S
Dividend yield (%)
0.0 1.4 2.8 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
Dividend yield %

Frequently asked questions

Is USPH growing its revenue and profit?

Over the past 5 years, U S Physical Therapy Inc /Nv's revenue has grown 13.0% per year, and net income grown 2.4% per year. These are computed facts, not advice.

How much debt does USPH have?

As of FY2025, U S Physical Therapy Inc /Nv reported $162M of total debt against $36M of cash.

What is USPH's profit margin?

In FY2025, gross margin was 19.2%, operating margin 11.1%, and net margin 5.1%.

What is USPH's P/E ratio?

As of Jun '26, U S Physical Therapy Inc /Nv traded at a price-to-earnings ratio of about 25.5× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.